ProShare Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.25M Sell
27,831
-5,650
-17% -$1.41M 0.01% 487
2025
Q4
$8.06M Buy
33,481
+2,155
+7% +$551K 0.01% 376
2025
Q3
$8.57M Sell
31,326
-894
-3% -$244K 0.02% 371
2025
Q2
$8.31M Buy
32,220
+2,147
+7% +$512K 0.02% 365
2025
Q1
$6.73M Buy
30,073
+3,442
+13% +$804K 0.02% 459
2024
Q4
$6.09M Buy
26,631
+2,410
+10% +$580K 0.01% 479
2024
Q3
$5.91M Sell
24,221
-2,401
-9% -$537K 0.01% 487
2024
Q2
$5.1M Buy
26,622
+1,522
+6% +$309K 0.01% 495
2024
Q1
$4.97M Sell
25,100
-584
-2% -$107K 0.01% 501
2023
Q4
$4.42M Sell
25,684
-1,793
-7% -$275K 0.01% 511
2023
Q3
$4.06M Buy
27,477
+3,928
+17% +$710K 0.01% 522
2023
Q2
$5.15M Buy
23,549
+655
+3% +$146K 0.01% 496
2023
Q1
$5.01M Buy
22,894
+3,062
+15% +$664K 0.02% 482
2022
Q4
$4.13M Sell
19,832
-120
-0.6% -$26.4K 0.01% 486
2022
Q3
$4.36M Sell
19,952
-2,265
-10% -$516K 0.02% 477
2022
Q2
$4.66M Sell
22,217
-8,689
-28% -$1.85M 0.02% 500
2022
Q1
$7.5M Sell
30,906
-778
-2% -$188K 0.02% 479
2021
Q4
$8.25M Buy
31,684
+7,175
+29% +$1.86M 0.02% 475
2021
Q3
$6.46M Sell
24,509
-592
-2% -$162K 0.02% 475
2021
Q2
$6.19M Sell
25,101
-3,365
-12% -$707K 0.02% 467
2021
Q1
$5.52M Buy
28,466
+3,073
+12% +$616K 0.02% 451
2020
Q4
$5.4M Buy
25,393
+1,563
+7% +$312K 0.02% 424
2020
Q3
$4.08M Buy
23,830
+5,031
+27% +$929K 0.02% 433
2020
Q2
$3.61M Buy
18,799
+3,853
+26% +$630K 0.02% 447
2020
Q1
$2.2M Sell
14,946
-10,309
-41% -$1.64M 0.02% 473
2019
Q4
$3.91M Buy
25,255
+5,198
+26% +$749K 0.02% 497
2019
Q3
$2.71M Buy
20,057
+1,266
+7% +$166K 0.02% 530
2019
Q2
$2.29M Sell
18,791
-30,092
-62% -$3.33M 0.01% 557
2019
Q1
$5.08M Buy
48,883
+27,652
+130% +$2.85M 0.03% 407
2018
Q4
$2.42M Buy
21,231
+1,270
+6% +$136K 0.02% 534
2018
Q3
$2.3M Sell
19,961
-1,805
-8% -$198K 0.02% 574
2018
Q2
$2.25M Sell
21,766
-1,625
-7% -$164K 0.02% 595
2018
Q1
$2.3M Buy
23,391
+750
+3% +$70.9K 0.02% 588
2017
Q4
$1.92M Buy
22,641
+6,573
+41% +$543K 0.01% 619
2017
Q3
$1.24M Buy
16,068
+3,246
+25% +$248K 0.01% 683
2017
Q2
$998K Sell
12,822
-2,020
-14% -$145K 0.01% 737
2017
Q1
$1.07M Sell
14,842
-821
-5% -$56.7K 0.01% 728
2016
Q4
$972K Buy
15,663
+2,563
+20% +$157K 0.01% 791
2016
Q3
$849K Sell
13,100
-3,283
-20% -$219K 0.01% 733
2016
Q2
$1.04M Sell
16,383
-47
-0.3% -$2.77K 0.01% 706
2016
Q1
$950K Sell
16,430
-1,666
-9% -$94.3K 0.01% 719
2015
Q4
$972K Buy
18,096
+1,633
+10% +$92K 0.01% 748
2015
Q3
$839K Sell
16,463
-8,951
-35% -$482K 0.01% 734
2015
Q2
$1.43M Sell
25,414
-771
-3% -$48.7K 0.02% 625
2015
Q1
$1.88M Sell
26,185
-3,102
-11% -$201K 0.02% 582
2014
Q4
$1.64M Sell
29,287
-46,865
-62% -$2.45M 0.02% 636
2014
Q3
$3.75M Buy
76,152
+7,706
+11% +$392K 0.05% 385
2014
Q2
$3.46M Buy
68,446
+49,525
+262% +$2.45M 0.04% 428
2014
Q1
$846K Sell
18,921
-87,369
-82% -$3.92M 0.01% 1433
2013
Q4
$5M Buy
106,290
+89,913
+549% +$4.55M 0.07% 304
2013
Q3
$865K Buy
16,377
+5,004
+44% +$243K 0.02% 983
2013
Q2
$513K Buy
+11,373
New +$540K 0.01% 1318

Other funds holding RMD

ProShare Advisors's RMD Position: Q1 2026 in Review

ProShare Advisors reduced its ResMed (RMD) stake by 17% in Q1 2026, selling an estimated $1.41M and leaving 27,831 shares worth $6.25M. The position accounts for 0.01% of the portfolio, ranked #487.

ProShare Advisors first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.57M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • ProShare Advisors held 27,831 shares of ResMed worth $6.25M as of Q1 2026.
  • ProShare Advisors sold 5,650 ResMed shares in Q1 2026, an estimated $1.41M.
  • ResMed made up 0.01% of ProShare Advisors's portfolio in Q1 2026, its #487 holding.
  • ProShare Advisors first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • ProShare Advisors's ResMed position peaked at $8.57M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.